Skip to main content
Rocket Doctor AI Inc. logo

Rocket Doctor AI Inc. — Investor Relations & Filings

Ticker · AIDR CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 226 across all filing types
Latest filing 2025-10-15 Regulatory Filings
Country CA Canada
Listing CSE AIDR

About Rocket Doctor AI Inc.

https://www.rocketdoctor.ai/

Rocket Doctor AI Inc. is a healthcare technology company specializing in medical AI solutions designed to improve patient care accessibility and outcomes across the full patient journey. The company delivers physician-built, AI-powered tools, including healthcare APIs and a proprietary "AI brain" that powers scalable clinical and diagnostic solutions. Rocket Doctor AI operates an AI-enhanced digital health platform and marketplace, often characterized as a "Shopify for physicians," which facilitates virtual health services and empowers medical professionals. Core offerings also include AI-powered clinical training and assessment tools for medical learners, an AI-powered voice assistant for mental health and care support, and advanced AI-powered Clinical Decision Support systems. The company focuses on delivering high-quality, accessible healthcare solutions throughout North America.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release announcing that Rocket Doctor AI’s subsidiary has been awarded an NIH SBIR Phase II grant. It does not present financial results (quarterly or annual), share issues, management change, call transcript, or other specific filing types. It is a general corporate announcement (press release) with no formal report attached. Therefore it falls under the fallback “Regulatory Filings” category (RNS).
2025-10-15 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a GlobeNewswire press release announcing that Rocket Doctor AI Inc. has secured advisory services and non-dilutive funding from two government programs (NRC IRAP and CanExport SMEs). It focuses on financing activities and the use of proceeds for product development and U.S. market expansion. This fits the definition of a Capital/Financing Update (CAP).
2025-10-09 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing that Rocket Doctor AI has signed contracts with major U.S. insurers to expand patient access; it describes business development rather than financial results, regulatory disclosures, management changes, or share transactions. It does not fit any specific predefined category (e.g., earnings release, financing update, M&A, director dealings, etc.), so it falls into the fallback category “Regulatory Filings” (RNS).
2025-10-08 English
Consent letter of issuer's legal counsel.pdf
Regulatory Filings Classification · 1% confidence The document is a legal counsel consent letter filed with multiple Canadian securities commissions in connection with a prospectus supplement for a Short Form Base Shelf Prospectus. It does not itself announce a share issue, dividend, board change, or present financial results. It is part of regulatory offering documentation and does not fit any more specific category, so it is classified as a general regulatory filing (RNS).
2025-09-26 English
Prospectus (non pricing) supplement (other than ATM) – English.pdf
Capital/Financing Update Classification · 1% confidence The document is a Prospectus Supplement and accompanying short form base shelf prospectus relating to the public offering and distribution of common shares and warrants. It provides detailed terms of the financing, plan of distribution, use of proceeds, risk factors, and related information for a capital raise. This is not a full annual or interim report, earnings release, or management notice, but rather a securities offering prospectus focused on fundraising activities. It therefore falls under Capital/Financing Update.
2025-09-26 English
Auditors' consent letter.pdf
Audit Report / Information Classification · 1% confidence The document is an auditor’s consent letter from Welch LLP to the Canadian securities commissions, allowing the use of their June 20, 2025 audit report in a prospectus supplement for the distribution of shares and warrants. This is not the company’s financing announcement itself but is a standalone auditor document related to the audit report. Accordingly, it falls under “Audit Report / Information” (AR). FY 2025
2025-09-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.